aluates Reports

$ 0.0

Automative

Global Frovatriptan Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-27F8029

Global Frovatriptan Market Insights Forecast to 2028

BUY CHAPTERS

Global Frovatriptan Market Research Report 2025

Code: QYRE-Auto-27F8029

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ligand Pharmaceuticals

Endo Pharmaceuticals

Doc Generici

Menarini

Novartis

ALMAC

Glenmark Generics

TEVA

Zambon

Apotex

G.L. Pharma

Chanelle Pharma

Frovatriptan Market Size

The global market for Frovatriptan was valued at US$ 899 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Frovatriptan Market

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Frovatriptan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frovatriptan.

The Frovatriptan market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Frovatriptan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Frovatriptan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Frovatriptan Market Report

Report Metric	Details
Report Name	Frovatriptan Market
Accounted market size in year	US$ 899 million
Forecasted market size in 2031	US$ 1251 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hospital Drug Store
Segment by Application	Menstrual Migraines Migraine with Aura Migraine without Aura
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva, Zambon, Apotex, G.L. Pharma, Chanelle Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Frovatriptan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Frovatriptan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Frovatriptan Market growing?

Ans: The Frovatriptan Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Frovatriptan Market size in 2031?

Ans: The Frovatriptan Market size in 2031 will be US$ 1251 million.

Who are the main players in the Frovatriptan Market report?

Ans: The main players in the Frovatriptan Market are Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva, Zambon, Apotex, G.L. Pharma, Chanelle Pharma

What are the Application segmentation covered in the Frovatriptan Market report?

Ans: The Applications covered in the Frovatriptan Market report are Menstrual Migraines, Migraine with Aura, Migraine without Aura

What are the Type segmentation covered in the Frovatriptan Market report?

Ans: The Types covered in the Frovatriptan Market report are Hospital, Drug Store

Recommended Reports

Migraine & Headaches

Neurology Therapeutics

Mental Health Drugs

1 Frovatriptan Market Overview

1.1 Product Definition

1.2 Frovatriptan by Type

1.2.1 Global Frovatriptan Market Value Comparison by Type (2024 VS 2031)

1.2.2 Hospital

1.2.3 Drug Store

1.3 Frovatriptan by Application

1.3.1 Global Frovatriptan Market Value by Application (2024 VS 2031)

1.3.2 Menstrual Migraines

1.3.3 Migraine with Aura

1.3.4 Migraine without Aura

1.4 Global Frovatriptan Market Size Estimates and Forecasts

1.4.1 Global Frovatriptan Revenue 2020-2031

1.4.2 Global Frovatriptan Sales 2020-2031

1.4.3 Global Frovatriptan Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Frovatriptan Market Competition by Manufacturers

2.1 Global Frovatriptan Sales Market Share by Manufacturers (2020-2025)

2.2 Global Frovatriptan Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Frovatriptan Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Frovatriptan, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Frovatriptan, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Frovatriptan, Product Type & Application

2.7 Global Key Manufacturers of Frovatriptan, Date of Enter into This Industry

2.8 Global Frovatriptan Market Competitive Situation and Trends

2.8.1 Global Frovatriptan Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Frovatriptan Players Market Share by Revenue

2.8.3 Global Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Frovatriptan Market Scenario by Region

3.1 Global Frovatriptan Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Frovatriptan Sales by Region: 2020-2031

3.2.1 Global Frovatriptan Sales by Region: 2020-2025

3.2.2 Global Frovatriptan Sales by Region: 2026-2031

3.3 Global Frovatriptan Revenue by Region: 2020-2031

3.3.1 Global Frovatriptan Revenue by Region: 2020-2025

3.3.2 Global Frovatriptan Revenue by Region: 2026-2031

3.4 North America Frovatriptan Market Facts & Figures by Country

3.4.1 North America Frovatriptan Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Frovatriptan Sales by Country (2020-2031)

3.4.3 North America Frovatriptan Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Frovatriptan Market Facts & Figures by Country

3.5.1 Europe Frovatriptan Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Frovatriptan Sales by Country (2020-2031)

3.5.3 Europe Frovatriptan Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Frovatriptan Market Facts & Figures by Region

3.6.1 Asia Pacific Frovatriptan Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Frovatriptan Sales by Region (2020-2031)

3.6.3 Asia Pacific Frovatriptan Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Frovatriptan Market Facts & Figures by Country

3.7.1 Latin America Frovatriptan Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Frovatriptan Sales by Country (2020-2031)

3.7.3 Latin America Frovatriptan Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Frovatriptan Market Facts & Figures by Country

3.8.1 Middle East and Africa Frovatriptan Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Frovatriptan Sales by Country (2020-2031)

3.8.3 Middle East and Africa Frovatriptan Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Frovatriptan Sales by Type (2020-2031)

4.1.1 Global Frovatriptan Sales by Type (2020-2025)

4.1.2 Global Frovatriptan Sales by Type (2026-2031)

4.1.3 Global Frovatriptan Sales Market Share by Type (2020-2031)

4.2 Global Frovatriptan Revenue by Type (2020-2031)

4.2.1 Global Frovatriptan Revenue by Type (2020-2025)

4.2.2 Global Frovatriptan Revenue by Type (2026-2031)

4.2.3 Global Frovatriptan Revenue Market Share by Type (2020-2031)

4.3 Global Frovatriptan Price by Type (2020-2031)

5 Segment by Application

5.1 Global Frovatriptan Sales by Application (2020-2031)

5.1.1 Global Frovatriptan Sales by Application (2020-2025)

5.1.2 Global Frovatriptan Sales by Application (2026-2031)

5.1.3 Global Frovatriptan Sales Market Share by Application (2020-2031)

5.2 Global Frovatriptan Revenue by Application (2020-2031)

5.2.1 Global Frovatriptan Revenue by Application (2020-2025)

5.2.2 Global Frovatriptan Revenue by Application (2026-2031)

5.2.3 Global Frovatriptan Revenue Market Share by Application (2020-2031)

5.3 Global Frovatriptan Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ligand Pharmaceuticals

6.1.1 Ligand Pharmaceuticals Company Information

6.1.2 Ligand Pharmaceuticals Description and Business Overview

6.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ligand Pharmaceuticals Frovatriptan Product Portfolio

6.1.5 Ligand Pharmaceuticals Recent Developments/Updates

6.2 Endo Pharmaceuticals

6.2.1 Endo Pharmaceuticals Company Information

6.2.2 Endo Pharmaceuticals Description and Business Overview

6.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Endo Pharmaceuticals Frovatriptan Product Portfolio

6.2.5 Endo Pharmaceuticals Recent Developments/Updates

6.3 Doc Generici

6.3.1 Doc Generici Company Information

6.3.2 Doc Generici Description and Business Overview

6.3.3 Doc Generici Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Doc Generici Frovatriptan Product Portfolio

6.3.5 Doc Generici Recent Developments/Updates

6.4 Menarini

6.4.1 Menarini Company Information

6.4.2 Menarini Description and Business Overview

6.4.3 Menarini Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Menarini Frovatriptan Product Portfolio

6.4.5 Menarini Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Company Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Novartis Frovatriptan Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Almac

6.6.1 Almac Company Information

6.6.2 Almac Description and Business Overview

6.6.3 Almac Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Almac Frovatriptan Product Portfolio

6.6.5 Almac Recent Developments/Updates

6.7 Glenmark Generics

6.7.1 Glenmark Generics Company Information

6.7.2 Glenmark Generics Description and Business Overview

6.7.3 Glenmark Generics Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Glenmark Generics Frovatriptan Product Portfolio

6.7.5 Glenmark Generics Recent Developments/Updates

6.8 Teva

6.8.1 Teva Company Information

6.8.2 Teva Description and Business Overview

6.8.3 Teva Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Teva Frovatriptan Product Portfolio

6.8.5 Teva Recent Developments/Updates

6.9 Zambon

6.9.1 Zambon Company Information

6.9.2 Zambon Description and Business Overview

6.9.3 Zambon Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Zambon Frovatriptan Product Portfolio

6.9.5 Zambon Recent Developments/Updates

6.10 Apotex

6.10.1 Apotex Company Information

6.10.2 Apotex Description and Business Overview

6.10.3 Apotex Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Apotex Frovatriptan Product Portfolio

6.10.5 Apotex Recent Developments/Updates

6.11 G.L. Pharma

6.11.1 G.L. Pharma Company Information

6.11.2 G.L. Pharma Description and Business Overview

6.11.3 G.L. Pharma Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.11.4 G.L. Pharma Frovatriptan Product Portfolio

6.11.5 G.L. Pharma Recent Developments/Updates

6.12 Chanelle Pharma

6.12.1 Chanelle Pharma Company Information

6.12.2 Chanelle Pharma Description and Business Overview

6.12.3 Chanelle Pharma Frovatriptan Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Chanelle Pharma Frovatriptan Product Portfolio

6.12.5 Chanelle Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Frovatriptan Industry Chain Analysis

7.2 Frovatriptan Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Frovatriptan Production Mode & Process Analysis

7.4 Frovatriptan Sales and Marketing

7.4.1 Frovatriptan Sales Channels

7.4.2 Frovatriptan Distributors

7.5 Frovatriptan Customer Analysis

8 Frovatriptan Market Dynamics

8.1 Frovatriptan Industry Trends

8.2 Frovatriptan Market Drivers

8.3 Frovatriptan Market Challenges

8.4 Frovatriptan Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Ligand Pharmaceuticals

Endo Pharmaceuticals

Doc Generici

Menarini

Novartis

ALMAC

Glenmark Generics

TEVA

Zambon

Apotex

G.L. Pharma

Chanelle Pharma

List of Tables

Table 1. Global Frovatriptan Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Frovatriptan Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Frovatriptan Market Competitive Situation by Manufacturers in 2024

Table 4. Global Frovatriptan Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Frovatriptan Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Frovatriptan Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Frovatriptan Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Frovatriptan Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Frovatriptan, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Frovatriptan, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Frovatriptan, Product Type & Application

Table 12. Global Key Manufacturers of Frovatriptan, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Frovatriptan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frovatriptan as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Frovatriptan Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Frovatriptan Sales by Region (2020-2025) & (K Units)

Table 18. Global Frovatriptan Sales Market Share by Region (2020-2025)

Table 19. Global Frovatriptan Sales by Region (2026-2031) & (K Units)

Table 20. Global Frovatriptan Sales Market Share by Region (2026-2031)

Table 21. Global Frovatriptan Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Frovatriptan Revenue Market Share by Region (2020-2025)

Table 23. Global Frovatriptan Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Frovatriptan Revenue Market Share by Region (2026-2031)

Table 25. North America Frovatriptan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Frovatriptan Sales by Country (2020-2025) & (K Units)

Table 27. North America Frovatriptan Sales by Country (2026-2031) & (K Units)

Table 28. North America Frovatriptan Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Frovatriptan Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Frovatriptan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Frovatriptan Sales by Country (2020-2025) & (K Units)

Table 32. Europe Frovatriptan Sales by Country (2026-2031) & (K Units)

Table 33. Europe Frovatriptan Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Frovatriptan Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Frovatriptan Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Frovatriptan Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Frovatriptan Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Frovatriptan Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Frovatriptan Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Frovatriptan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Frovatriptan Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Frovatriptan Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Frovatriptan Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Frovatriptan Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Frovatriptan Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Frovatriptan Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Frovatriptan Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Frovatriptan Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Frovatriptan Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Frovatriptan Sales (K Units) by Type (2020-2025)

Table 51. Global Frovatriptan Sales (K Units) by Type (2026-2031)

Table 52. Global Frovatriptan Sales Market Share by Type (2020-2025)

Table 53. Global Frovatriptan Sales Market Share by Type (2026-2031)

Table 54. Global Frovatriptan Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Frovatriptan Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Frovatriptan Revenue Market Share by Type (2020-2025)

Table 57. Global Frovatriptan Revenue Market Share by Type (2026-2031)

Table 58. Global Frovatriptan Price (US$/Unit) by Type (2020-2025)

Table 59. Global Frovatriptan Price (US$/Unit) by Type (2026-2031)

Table 60. Global Frovatriptan Sales (K Units) by Application (2020-2025)

Table 61. Global Frovatriptan Sales (K Units) by Application (2026-2031)

Table 62. Global Frovatriptan Sales Market Share by Application (2020-2025)

Table 63. Global Frovatriptan Sales Market Share by Application (2026-2031)

Table 64. Global Frovatriptan Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Frovatriptan Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Frovatriptan Revenue Market Share by Application (2020-2025)

Table 67. Global Frovatriptan Revenue Market Share by Application (2026-2031)

Table 68. Global Frovatriptan Price (US$/Unit) by Application (2020-2025)

Table 69. Global Frovatriptan Price (US$/Unit) by Application (2026-2031)

Table 70. Ligand Pharmaceuticals Company Information

Table 71. Ligand Pharmaceuticals Description and Business Overview

Table 72. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Ligand Pharmaceuticals Frovatriptan Product

Table 74. Ligand Pharmaceuticals Recent Developments/Updates

Table 75. Endo Pharmaceuticals Company Information

Table 76. Endo Pharmaceuticals Description and Business Overview

Table 77. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Endo Pharmaceuticals Frovatriptan Product

Table 79. Endo Pharmaceuticals Recent Developments/Updates

Table 80. Doc Generici Company Information

Table 81. Doc Generici Description and Business Overview

Table 82. Doc Generici Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Doc Generici Frovatriptan Product

Table 84. Doc Generici Recent Developments/Updates

Table 85. Menarini Company Information

Table 86. Menarini Description and Business Overview

Table 87. Menarini Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Menarini Frovatriptan Product

Table 89. Menarini Recent Developments/Updates

Table 90. Novartis Company Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Novartis Frovatriptan Product

Table 94. Novartis Recent Developments/Updates

Table 95. Almac Company Information

Table 96. Almac Description and Business Overview

Table 97. Almac Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Almac Frovatriptan Product

Table 99. Almac Recent Developments/Updates

Table 100. Glenmark Generics Company Information

Table 101. Glenmark Generics Description and Business Overview

Table 102. Glenmark Generics Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Glenmark Generics Frovatriptan Product

Table 104. Glenmark Generics Recent Developments/Updates

Table 105. Teva Company Information

Table 106. Teva Description and Business Overview

Table 107. Teva Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Teva Frovatriptan Product

Table 109. Teva Recent Developments/Updates

Table 110. Zambon Company Information

Table 111. Zambon Description and Business Overview

Table 112. Zambon Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Zambon Frovatriptan Product

Table 114. Zambon Recent Developments/Updates

Table 115. Apotex Company Information

Table 116. Apotex Description and Business Overview

Table 117. Apotex Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Apotex Frovatriptan Product

Table 119. Apotex Recent Developments/Updates

Table 120. G.L. Pharma Company Information

Table 121. G.L. Pharma Description and Business Overview

Table 122. G.L. Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. G.L. Pharma Frovatriptan Product

Table 124. G.L. Pharma Recent Developments/Updates

Table 125. Chanelle Pharma Company Information

Table 126. Chanelle Pharma Description and Business Overview

Table 127. Chanelle Pharma Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Chanelle Pharma Frovatriptan Product

Table 129. Chanelle Pharma Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Frovatriptan Distributors List

Table 133. Frovatriptan Customers List

Table 134. Frovatriptan Market Trends

Table 135. Frovatriptan Market Drivers

Table 136. Frovatriptan Market Challenges

Table 137. Frovatriptan Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Frovatriptan

Figure 2. Global Frovatriptan Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Frovatriptan Market Share by Type: 2024 & 2031

Figure 4. Hospital Product Picture

Figure 5. Drug Store Product Picture

Figure 6. Global Frovatriptan Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Frovatriptan Market Share by Application: 2024 & 2031

Figure 8. Menstrual Migraines

Figure 9. Migraine with Aura

Figure 10. Migraine without Aura

Figure 11. Global Frovatriptan Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Frovatriptan Market Size (2020-2031) & (US$ Million)

Figure 13. Global Frovatriptan Sales (2020-2031) & (K Units)

Figure 14. Global Frovatriptan Average Price (US$/Unit) & (2020-2031)

Figure 15. Frovatriptan Report Years Considered

Figure 16. Frovatriptan Sales Share by Manufacturers in 2024

Figure 17. Global Frovatriptan Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Frovatriptan Players: Market Share by Revenue in Frovatriptan in 2024

Figure 19. Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Frovatriptan Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Frovatriptan Sales Market Share by Country (2020-2031)

Figure 22. North America Frovatriptan Revenue Market Share by Country (2020-2031)

Figure 23. United States Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Frovatriptan Sales Market Share by Country (2020-2031)

Figure 26. Europe Frovatriptan Revenue Market Share by Country (2020-2031)

Figure 27. Germany Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Frovatriptan Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Frovatriptan Revenue Market Share by Region (2020-2031)

Figure 34. China Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Frovatriptan Sales Market Share by Country (2020-2031)

Figure 44. Latin America Frovatriptan Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Frovatriptan Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Frovatriptan Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Frovatriptan Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Frovatriptan by Type (2020-2031)

Figure 54. Global Revenue Market Share of Frovatriptan by Type (2020-2031)

Figure 55. Global Frovatriptan Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Frovatriptan by Application (2020-2031)

Figure 57. Global Revenue Market Share of Frovatriptan by Application (2020-2031)

Figure 58. Global Frovatriptan Price (US$/Unit) by Application (2020-2031)

Figure 59. Frovatriptan Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Triptans for Migraine Headaches Market Research Report 2025

Global Triptan Market Insights Forecast to 2030

Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rizatriptan Market Research Report 2024

Global Zolmitriptan Market Insights Forecast to 2030

Global Rizatriptan Benzoate Tablets Market Research Report 2025

Global Eletriptan Market Insights Forecast to 2030

Nortriptyline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Migraine Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Migraine Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Naratriptan Hydrochloride Market Research Report 2024

Global Rizatriptan Benzoate API Market Research Report 2025

Mefenamic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Migraine Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Opipramol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pregabalin Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acute Migraine Treatments Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions